Coenzyme Q10 as a possible treatment for neurodegenerative diseases.

It has been demonstrated that CoQ10 can protect against striatal lesions produced by the mitochondrial toxins malonate and 3-nitropropionic acid and show additive efficacy when combined with the N-methyl-D-aspartate (NMDA) receptor antagonist, remacemide.